Abstract
#Clinicaltrials are a key resource for the discovery of new
#diagnostic, treatment and #prevention methods for disease.
Many of today’s most introduced prevention and treatment
modalities are based on previous clinical trial results. Clinical
trials are an important part of improving quality of health care
[1]. Facilitators of participation in clinical trials have been
linked to recommendations by reliable health care providers, a
supportive family, satisfactory doctor-patient relationship that
depends on culture, financial incentives, anticipation of a personal
benefit to participants, convenience to #participants and culturally
appropriate advertisements [2]. To address such facilitators and
barriers of clinical trial participation in communities, we report our
institutional review board (IRB) of Matsunami General Hospital [3].
A typical central medical institution anchor of the region, Japan.
https://biomedres.us/abstracts/BJSTR.MS.ID.000634.php
https://biomedres.us/pdfs/BJSTR.MS.ID.000634.pdf
https://biomedres.us/fulltexts/BJSTR.MS.ID.000634.php
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.